Liquidia Corp — Director's Dealing 2023

Jan 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2023-01-03

Reporting Person: JEFFS ROGER (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-03	Common Stock	M	15807	—	Acquired	207249	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-03	Restricted Stock Unit	$	M	15807	Disposed		Common Stock (15807)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	46595	Indirect
Common Stock	1541667	Indirect

Footnotes

F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F2: On January 3, 2022, the Reporting Person was granted 63,230 RSUs (the "2022 RSUs") with 25% vesting quarterly through the first anniversary of the grant date. As of January 3, 2023, the 2022 RSUs have fully vested.

F3: The number of securities shown to be beneficially owned following the transaction being reported in this Form 4 reflects a downward adjustment of 15,808 shares of common stock due to a previous clerical error in double counting a vested portion of the 2022 RSUs in that certain previous Form 4 filed by the Reporting Person on October 4, 2022.

F4: The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.

F5: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.